Less Ads, More Data, More Tools Register for FREE

Rule 19.6(c) Confirmation

Today 07:00

RNS Number : 3543I
bd-capital Partners Limited
16 June 2026
 

THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE 19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") WHICH, INTER ALIA, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF A PERIOD OF 12 MONTHS FROM THE DATE ON WHICH THE OFFER PERIOD ENDED CONFIRMING WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED INTENTIONS.

FOR IMMEDIATE RELEASE

16 June 2026

Einstein Bidco Limited

 Rule 19.6(c) confirmation in respect of stated post-offer intentions for Science in Sport plc ("SiS")

Einstein Bidco Limited ("Bidco") announces that, further to the completion of the recommended acquisition pursuant to which Bidco (a company indirectly wholly-owned by funds advised by bd-capital Partners Limited ("bd-capital")) acquired the entire issued and to be issued share capital of SiS by means of a court-approved scheme of arrangement which became effective on 16 June 2025, Bidco has duly confirmed in writing to the Panel on Takeovers and Mergers in accordance with the requirements of Rule 19.6(c) of the Code that it has complied with the post-offer intention statements made pursuant to Rules 2.7(c)(viii) and 24.2 of the Code, as originally detailed in its announcement made under Rule 2.7 of the Code on 17 April 2025, and the scheme circular published on 6 May 2025.

 

Contacts:

Bidco / bd-capital Partners Limited

+44 (0) 781 4395224

Andrew Dawson

Andrey Russinov

Investec Bank plc (Financial Adviser to bd-capital / Bidco)

+44 (0) 20 7597 4000

Oliver Cardigan

Maria Gomez de Olea

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPLELFFQQLZBBB

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS